-
J.P Morgan Comments On J.P Morgan's Earnings Outperformance
Wednesday, January 26, 2011 - 9:14am | 207Stryker (NYSE: SYK) posted full 4Q results Tuesday night that were in line with its earlier positive preannouncement, with sales of $1.995B coming in $50M above the prior Street consensus. The 4Q upside was driven by a strong orthopedic performance, as Recon revenue of $1.166B was $26M better than...
-
St. Jude Medical Reports Q4 EPS of $0.75
Wednesday, January 26, 2011 - 8:34am | 57St. Jude Medical (NYSE: STJ) reports its Q4 adjusted EPS at $0.75, beating the consensus of $0.74. STJ reports its Q4 revenue at $1.35 billion, versus the consensus of $1.32 billion. STJ shares fell 0.66% to $42.34 in after-hours trading. Read more from Benzinga's Company news.
-
St. Jude Medical Reports Q4 EPS of $.62 vs. $.74
Wednesday, January 26, 2011 - 8:31am | 165St. Jude Medical, Inc. (NYSE: STJ) today reported sales and net earnings for the fourth quarter and year ended Jan. 1, 2011. The Company reported net sales of $1.350 billion in the fourth quarter of 2010, an increase of 12 percent over the $1.203 billion in the fourth quarter of 2009 including a $...
-
Deutsche Bank Maintains Hold on Stryker (SYK)
Wednesday, January 26, 2011 - 8:27am | 129Deutsche Bank is out with its report on Stryker (NYSE: SYK), maintaining Hold on SYK. In a note to clients, Deutsche Bank writes, "Over the past few years, Stryker has actively shifted its business mix away from orthopedics through acquisitions, most recently and notably Boston Scientific's...
-
Deutsche Bank Has Hold On Stryker (SYK)
Wednesday, January 26, 2011 - 8:19am | 189Deutsche Bank has a Hold rating on shares of Stryker (NYSE: SYK) after it reported earnings yesterday. In a note to clients, Deutsche Bank writes, "Stryker's hip sales were up 6% on a constant currency. US hips were up 7% indicative of traction with ADM and Rejuvenate while the OUS business...
-
JP Morgan Raises PT On Stryker To $62
Wednesday, January 26, 2011 - 8:08am | 27JP Morgan has raised the price target on Stryker Corporation (NYSE: SYK) from $57 to $62 and maintains its Neutral rating.
-
Mindray Books Big Order - Analyst Blog
Tuesday, January 25, 2011 - 7:01pm | 557Leading Chinese medical devices maker Mindray Medical International Limited (MR) has sealed the biggest contract for its patient monitoring systems in Canada. According to the company and its Canadian partner and distributor Ultra-Portable Inc, installation of the patient monitors has already...
-
BSX Evolves with EVOLVE Trial - Analyst Blog
Tuesday, January 25, 2011 - 6:31pm | 568Recently, Boston Scientific Corporation (BSX) completed its enrollment for the EVOLVE trial, which is meant to evaluate its fourth generation Synergy coronary stent. Patient enrollment had begun in late July 2010. The trial will compare Synergy with Promus Element everolimus-eluting coronary...
-
Mindray Books Big Order - Analyst Blog
Tuesday, January 25, 2011 - 6:27pm | 557Leading Chinese medical devices maker Mindray Medical International Limited (MR) has sealed the biggest contract for its patient monitoring systems in Canada. According to the company and its Canadian partner and distributor Ultra-Portable Inc, installation of the patient monitors has already...
-
AngioDynamics Halted; Receives FDA Warning Letter (ANGO)
Tuesday, January 25, 2011 - 6:24pm | 184AngioDynamics (NASDAQ: ANGO) today announced the receipt of a warning letter from the U.S. Food and Drug Administration (FDA) regarding certain aspects of the Company's marketing program for its NanoKnife® System. The NanoKnife System continues to be commercially available in the United States...
-
BSX Evolves with EVOLVE Trial - Analyst Blog
Tuesday, January 25, 2011 - 5:53pm | 568Recently, Boston Scientific Corporation (BSX) completed its enrollment for the EVOLVE trial, which is meant to evaluate its fourth generation Synergy coronary stent. Patient enrollment had begun in late July 2010. The trial will compare Synergy with Promus Element everolimus-eluting coronary...
-
Stryker Corp. Reports Q4 EPS of $0.93 vs. $0.91; Revenues $1.96B vs. $1.95B
Tuesday, January 25, 2011 - 5:01pm | 29Stryker Corp. (NYSE: SYK) reports Q4 earnings of $0.93 versus $0.91 estimate. Stryker Corp. reports Q4 revenues of $1.96 billion versus estimates of $1.95 billion.
-
Tuesday's Put/Call Ratio Leaders (EMS, CMED, NWSA, DHR, SLXP)
Tuesday, January 25, 2011 - 1:32pm | 92Here is a quick peek at stocks that have abnormally high daily put/call ratios today relative to their average…. 1. Emergency Medical Services (NYSE: EMS) 2,866 puts, 50 calls 2. China Medical Technologies (NASDAQ: CMED) 6,867 puts, 230 calls 3. News Corp. (NASDAQ: NWSA) 5,289 puts, 217 calls 4....
-
Earnings Preview: St. Jude - Analyst Blog
Tuesday, January 25, 2011 - 11:31am | 1174Medical devices giant St. Jude Medical (STJ) is slated to report its fourth quarter and fiscal 2010 results before the market opens on Wednesday, January 26. The Minnesota-based company, on January 12, reported healthy preliminary sales for the fourth quarter. St. Jude expects to post revenues of...
-
Earnings Preview: St. Jude - Analyst Blog
Tuesday, January 25, 2011 - 11:00am | 1174Medical devices giant St. Jude Medical (STJ) is slated to report its fourth quarter and fiscal 2010 results before the market opens on Wednesday, January 26. The Minnesota-based company, on January 12, reported healthy preliminary sales for the fourth quarter. St. Jude expects to post revenues of...